Aveanna Healthcare Holdings Inc.

Healthcare offers investors a potential combination of offense with forward earnings and defense with rising demand amid persistent macro-economic uncertainty. The healthcare sector is positioned for above-average long-term growth, supported by aging demographics, rising medical demand, and increased spending that's expected to outpace the broader economy. Strong forward revenue, EBITDA, and earnings growth demonstrate how select healthcare services and facilities companies can significantly outperform their sector peers.

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Aveanna (AVAH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH - Get Free Report) shares gapped down prior to trading on Wednesday. The stock had previously closed at $12.78, but opened at $12.29. Aveanna Healthcare shares last traded at $12.4710, with a volume of 1,038,627 shares traded. Analyst Ratings Changes A number of brokerages recently commented on AVAH. Raymond James

Here is how Aveanna Healthcare (AVAH) and Charles River Laboratories (CRL) have performed compared to their sector so far this year.